Probiotic and preservative uses of oil-emulsified probiotic encapsulations
    81.
    发明申请
    Probiotic and preservative uses of oil-emulsified probiotic encapsulations 有权
    益生菌和防腐剂使用油乳化益生菌包封

    公开(公告)号:US20060159745A1

    公开(公告)日:2006-07-20

    申请号:US11386159

    申请日:2006-03-21

    申请人: Bing Baksh

    发明人: Bing Baksh

    IPC分类号: A61K9/48

    摘要: An encapsulation system is provided comprising nitrogen-purge, instant bonding encapsulation method. Specifically, the encapsulation system comprises a composition, a two-piece capsule comprising a capsule cap and a capsule body; a gas to purge oxygen from the composition within the capsule; and a sealing solution to seal the capsule cap to the capsule body. Associated methods for encapsulating compositions using the encapsulation system are also provided.

    摘要翻译: 提供包括氮气吹扫,即时粘合封装方法的封装系统。 具体地,包封系统包括组合物,包括胶囊盖和胶囊主体的两片胶囊; 用于从胶囊内的组合物中清除氧气的气体; 以及将胶囊盖密封到胶囊主体的密封溶液。 还提供了使用封装系统封装组合物的相关方法。

    Probiotics in primary prevention of atopic diseases
    83.
    发明申请
    Probiotics in primary prevention of atopic diseases 有权
    益生菌一级预防特应性疾病

    公开(公告)号:US20030180272A1

    公开(公告)日:2003-09-25

    申请号:US10311706

    申请日:2002-12-19

    IPC分类号: A61K045/00

    摘要: The present invention is in the field of prophylaxis of allergies, and relates specifically to primary prevention of atopic diseases by administering probiotic bacteria, beneficial microbes of the healthy gut flora, pre- and postnatally to children at high risk of atopic diseases.

    摘要翻译: 本发明涉及过敏症的预防领域,特别涉及特应性疾病的一级预防,其特征在于,在特应性疾病高风险的儿童之前和之后施用益生菌,健康肠道菌群的有益微生物。

    Probiotic compounds derived from lactobacillus casei strain KE01
    84.
    发明申请
    Probiotic compounds derived from lactobacillus casei strain KE01 有权
    源自干酪芽孢杆菌菌株KE01的益生菌化合物

    公开(公告)号:US20020192202A1

    公开(公告)日:2002-12-19

    申请号:US10021871

    申请日:2001-12-17

    申请人: Probio Health

    IPC分类号: A61K045/00 A61K031/715

    摘要: Probiotic compositions are provided that comprise Lactobacillus casei strain KE01 having ATCC accession number ______. The disclosed probiotic compositions are useful in inhibiting enteric pathogen diseases in animals and in maintaining animal health. Methods of making and using Lactobacillus casei strain KE01 probiotic compositions are also disclosed as are methods of using these probiotic compositions.

    摘要翻译: 提供益生菌组合物,其包含具有ATCC登录号______的干酪乳杆菌菌株KE01。 所公开的益生菌组合物可用于抑制动物中的肠道病原体疾病和维持动物健康。 还公开了制备和使用干酪乳杆菌菌株KE01益生菌组合物的方法,是使用这些益生菌组合物的方法。

    Lactobacillus casei (BP-4442)
    89.
    发明授权
    Lactobacillus casei (BP-4442) 失效
    干酪乳杆菌(BP-4442)

    公开(公告)号:US5354687A

    公开(公告)日:1994-10-11

    申请号:US24087

    申请日:1993-03-01

    摘要: Described herein is a bacterium having high antimutagenicity against mutagens and belonging to the genus of Lactobacillus. The mutagens may comprise both a base-pair change mutagen and a frameshift mutagen. The bacterium preferably has high intestine reachability and can be Lactobacillus casei.

    摘要翻译: 本文描述了对诱变剂具有高抗诱变性并属于乳杆菌属的细菌。 诱变剂可以包含碱基对变异突变体和移码突变体。 细菌优选具有高肠可达性,并且可以是干酪乳杆菌(Lactobacillus casei)。

    Method for the determination of .alpha.-ketoisocaproate in biological
samples using D-.alpha.-hydroxyisocaproic dehydrogenase from
lactobacillus casei
    90.
    发明授权
    Method for the determination of .alpha.-ketoisocaproate in biological samples using D-.alpha.-hydroxyisocaproic dehydrogenase from lactobacillus casei 失效
    使用干酪乳杆菌的D-α-羟基异己酸脱氢酶测定生物样品中α-酮异己酸的方法

    公开(公告)号:US5264347A

    公开(公告)日:1993-11-23

    申请号:US924569

    申请日:1992-08-05

    IPC分类号: C12Q1/32 G01N33/68

    摘要: The selective determination of .alpha.-ketoisocaproate in samples of body fluids, especially in serum, is achieved, without previous separation, directly in the fluid and in the presence of NADH, by means of a KIC-specific D-.alpha.-hydroxy-isocaproic dehydrogenase that originates specifically from strains of Lactobacillus casei producing this enzyme, in particular strains of Lactobacillus casei subspecies pseudoplantarum or casei. The KIC determination is used, in particular, for diagnosing maple syrup urine disease. Expedient for this purpose are analytical kits which have a divisible stock of D-.alpha.-hydroxyisocaproic dehydrogenase from Lactobacillus casei, in particular from the Lactobacillus casei (DSM 20008).

    摘要翻译: 通过KIC特异性的D-羟基异己酸脱氢酶,可以直接在流体中和在NADH的存在下,在体液样品(特别是血清)中选择性测定α-酮异己酸盐,特别是在血清中。 其特异性来源于产生该酶的干酪乳杆菌菌株,特别是干酪乳杆菌亚种假单胞菌或干酪乳杆菌菌株。 KIC测定用于诊断枫糖尿病。 为此目的的便利是分析试剂盒,其具有来自干酪乳杆菌(Dactobacillus casei),特别是干酪乳杆菌(DSM 20008)的D-α-羟基异己酸脱氢酶的可分割原料。